Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: Need for Randomized Evidence

Affiliations

¹ Gustave-Roussy, Paris Sud University, Villejuif, France cecile.lepechoux@gustaveroussy.fr.
² Gustave-Roussy, Paris Sud University, Villejuif, France.
³ The University of Manchester, Manchester, United Kingdom.
⁴ Aix-Marseille University and Hospitals, Marseille, France.
⁵ Institut Sainte Catherine, Avignon, France.
⁶ Centre François Baclesse, Caen, France.
⁷ Northern General Hospital, Sheffield, United Kingdom.
⁸ University Hospital of Antwerp, Antwerp, Belgium.
⁹ Hospital Universitari Mutua Terrassa, Barcelona, Spain.
¹⁰ Centre Oscar Lambret, Lille, France.
¹¹ Freiburg University Medical Center, Freiburg im Breisgau, Germany.
¹² Centre Chirurgical Marie Lannelongue, Paris Sud University, Paris, France.
¹³ Centre Hospitalier Universitaire de Caen, Caen, France.

PMID: 26215941
DOI: 10.1200/JCO.2015.62.1458

Comment

Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: Need for Randomized Evidence

Cécile Le Péchoux et al. J Clin Oncol. 2015.

. 2015 Sep 10;33(26):2930-1.

doi: 10.1200/JCO.2015.62.1458. Epub 2015 Jul 27.

Authors

Affiliations

¹ Gustave-Roussy, Paris Sud University, Villejuif, France cecile.lepechoux@gustaveroussy.fr.
² Gustave-Roussy, Paris Sud University, Villejuif, France.
³ The University of Manchester, Manchester, United Kingdom.
⁴ Aix-Marseille University and Hospitals, Marseille, France.
⁵ Institut Sainte Catherine, Avignon, France.
⁶ Centre François Baclesse, Caen, France.
⁷ Northern General Hospital, Sheffield, United Kingdom.
⁸ University Hospital of Antwerp, Antwerp, Belgium.
⁹ Hospital Universitari Mutua Terrassa, Barcelona, Spain.
¹⁰ Centre Oscar Lambret, Lille, France.
¹¹ Freiburg University Medical Center, Freiburg im Breisgau, Germany.
¹² Centre Chirurgical Marie Lannelongue, Paris Sud University, Paris, France.
¹³ Centre Hospitalier Universitaire de Caen, Caen, France.

PMID: 26215941
DOI: 10.1200/JCO.2015.62.1458

No abstract available

PubMed Disclaimer

Comment in

Reply to C. Le Péchoux et al and B.S. Gill et al.
Robinson CG, Patel AP, DeWees T, Morgensztern D, Bradley JD, Puri V. Robinson CG, et al. J Clin Oncol. 2015 Sep 10;33(26):2932-3. doi: 10.1200/JCO.2015.62.5731. Epub 2015 Jul 27. J Clin Oncol. 2015. PMID: 26215956 No abstract available.

Comment on

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.
Robinson CG, Patel AP, Bradley JD, DeWees T, Waqar SN, Morgensztern D, Baggstrom MQ, Govindan R, Bell JM, Guthrie TJ, Colditz GA, Crabtree TD, Kreisel D, Krupnick AS, Patterson GA, Meyers BF, Puri V. Robinson CG, et al. J Clin Oncol. 2015 Mar 10;33(8):870-6. doi: 10.1200/JCO.2014.58.5380. Epub 2015 Feb 9. J Clin Oncol. 2015. PMID: 25667283 Free PMC article.

Cited by

PLNR≤20% may be a benefit from PORT for patients with IIIA-N2 NSCLC: a large population-based study.
Shang X, Li Z, Lin J, Wang H, Wang Z. Shang X, et al. Cancer Manag Res. 2018 Sep 17;10:3561-3567. doi: 10.2147/CMAR.S173856. eCollection 2018. Cancer Manag Res. 2018. PMID: 30271204 Free PMC article.
Multimodality therapy in subclassified stage IIIA-N2 non-small cell lung cancer patients according to the Robinson classification: heterogeneity and management.
Hofmann HS, Braess J, Leipelt S, Allgäuer M, Klinkhammer-Schalke M, Szoeke T, Grosser C, Pfeifer M, Ried M. Hofmann HS, et al. J Thorac Dis. 2018 Jun;10(6):3585-3594. doi: 10.21037/jtd.2018.05.203. J Thorac Dis. 2018. PMID: 30069356 Free PMC article.
Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!
Berzenji L, Beckers P, Van Schil PE. Berzenji L, et al. J Thorac Dis. 2019 May;11(Suppl 9):S1153-S1156. doi: 10.21037/jtd.2019.04.36. J Thorac Dis. 2019. PMID: 31245070 Free PMC article. No abstract available.
Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis.
Su L, Chen M, Su H, Dai Y, Chen S, Li J. Su L, et al. BMC Cancer. 2019 Oct 30;19(1):1023. doi: 10.1186/s12885-019-6141-z. BMC Cancer. 2019. PMID: 31666026 Free PMC article.
Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers.
Lou Y, Dholaria B, Soyano A, Hodge D, Cochuyt J, Manochakian R, Ko SJ, Thomas M, Johnson MM, Patel NM, Miller RC, Adjei AA, Ailawadhi S. Lou Y, et al. Cancer Med. 2018 Oct;7(10):4932-4942. doi: 10.1002/cam4.1749. Epub 2018 Sep 2. Cancer Med. 2018. PMID: 30175515 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: Need for Randomized Evidence

Affiliations

Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: Need for Randomized Evidence

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical